Pillar's NGS lab receives certification, state permit

By LabPulse.com staff writers

January 10, 2022 -- Pillar Biosciences' next-generation sequencing (NGS) laboratory has passed onsite inspection and recently received certification from the U.S. Department of Health and Human Services' Centers for Medicare and Medicaid Services (CMS), the company said.

The Natick, MA-based lab also received the state permit. All of this means the lab can support preclinical studies and clinical trials, with the longer-term potential to provide companion diagnostics for the company's pharmaceutical partners.

Pillar Biosciences will also support the development and validation of its NGS products through the lab.

Labcorp, Pillar Biosciences team up for genomic testing
Labcorp and Pillar Biosciences have signed an agreement to offer genomic cancer testing based on Pillar's next-generation sequencing technology.

Copyright © 2022 LabPulse.com

Last Updated ls 1/10/2022 12:54:56 PM